Regeneron Pharmaceuticals, Inc
Insiders
Last 12 monthsSales planned on beside the trades reported on , and whether each names a .
Planned ·
$13.0M
13 notices · 17,611 sh
Oct 2025 to Oct 2026
Reported ·
$9,473,035
78 sales · 0 buys
Oct 2025 to Jun 2026
The two figures cover different periods.
71 of 78 reported sales carry the 10b5-1 box.
under a no plan named▼ salesize is dollars
Form 144 notices, newest first
2026-09-03McCourt Marion, EVP Commercial$969,267
2026-09-02McCourt Marion, EVP Commercial$1,032,750
2026-09-02Guarini Kathryn, Director$340,000
2026-08-10Zoghbi Huda Y, Director$640,000
2026-08-10Guarini Kathryn, Board member$320,000
2026-07-02Arthur F. Ryan, Director$249,888
2026-02-19Zoghbi Huda Y, Director$1,294,020
Form 4, 2026-02-23: sold 1,638 at $781.33 Form 4 ↗
2026-02-09Pitofsky Jason, SVP Controller$1,594,534
Form 4, 2026-02-11: sold 2,036 at $778.52 Form 4 ↗
2026-02-09Arthur F. Ryan, Director$314,204
Form 4, 2026-02-11: sold 100 at $778.53 Form 4 ↗
2026-01-07Bassler Bonnie L, Director$1,200,000
Form 4, 2026-01-08: sold 1,500 at $800.00 Form 4 ↗
2025-11-20Bassler Bonnie L, Director$570,000
Form 4, 2025-11-24: sold 760 at $750.00 Form 4 ↗
2025-11-07Jason Pitofsky, SVP Controller$280,581
Form 4, 2025-11-10: sold 431 at $651.43 Form 4 ↗